JP2008509987A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509987A5
JP2008509987A5 JP2007526616A JP2007526616A JP2008509987A5 JP 2008509987 A5 JP2008509987 A5 JP 2008509987A5 JP 2007526616 A JP2007526616 A JP 2007526616A JP 2007526616 A JP2007526616 A JP 2007526616A JP 2008509987 A5 JP2008509987 A5 JP 2008509987A5
Authority
JP
Japan
Prior art keywords
triazolo
alkyl
group
compound
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007526616A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509987A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/002868 external-priority patent/WO2006018735A2/en
Publication of JP2008509987A publication Critical patent/JP2008509987A/ja
Publication of JP2008509987A5 publication Critical patent/JP2008509987A5/ja
Withdrawn legal-status Critical Current

Links

JP2007526616A 2004-08-18 2005-08-08 トリアゾロピリジン化合物 Withdrawn JP2008509987A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60234404P 2004-08-18 2004-08-18
PCT/IB2005/002868 WO2006018735A2 (en) 2004-08-18 2005-08-08 Triazolopyridine compounds

Publications (2)

Publication Number Publication Date
JP2008509987A JP2008509987A (ja) 2008-04-03
JP2008509987A5 true JP2008509987A5 (cg-RX-API-DMAC10.html) 2008-09-11

Family

ID=35735197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526616A Withdrawn JP2008509987A (ja) 2004-08-18 2005-08-08 トリアゾロピリジン化合物

Country Status (7)

Country Link
US (1) US20090209577A1 (cg-RX-API-DMAC10.html)
EP (1) EP1786811A2 (cg-RX-API-DMAC10.html)
JP (1) JP2008509987A (cg-RX-API-DMAC10.html)
BR (1) BRPI0514327A (cg-RX-API-DMAC10.html)
CA (1) CA2577478A1 (cg-RX-API-DMAC10.html)
MX (1) MX2007002050A (cg-RX-API-DMAC10.html)
WO (1) WO2006018735A2 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509985A (ja) * 2004-08-18 2008-04-03 ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー 炎症治療用の新規トリアゾロピリジン化合物
US7579360B2 (en) 2005-06-09 2009-08-25 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
JP5336375B2 (ja) * 2006-08-30 2013-11-06 セルゾーム リミテッド キナーゼ阻害剤としてのトリアゾール誘導体
EP1894931A1 (en) * 2006-08-30 2008-03-05 Cellzome Ag Triazole derivatives as kinase inhibitors
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8119658B2 (en) 2007-10-01 2012-02-21 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
UA102828C2 (en) 2007-11-27 2013-08-27 Целльзом Лимитед Amino triazoles as p13k inhibitors
JO3041B1 (ar) 2008-07-25 2016-09-05 Galapagos Nv مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
WO2010010184A1 (en) * 2008-07-25 2010-01-28 Galapagos Nv [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors
TWI453207B (zh) 2008-09-08 2014-09-21 Signal Pharm Llc 胺基三唑并吡啶,其組合物及使用其之治療方法
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
JO3030B1 (ar) 2009-06-26 2016-09-05 Galapagos Nv مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات
JP5775094B2 (ja) 2009-12-29 2015-09-09 イーライ リリー アンド カンパニー 統合失調症の処置に有用な選択的mGlu5受容体増強因子としてのテトラヒドロトリアゾロピリジン化合物
PT3511330T (pt) 2009-12-31 2020-12-24 Hutchison Medipharma Ltd Intermediário sintético útil na preparação de inibidores de triazolopiridina c-met
GB201321742D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201402070D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Pharmaceutical compositions for the treatment of inflammatory disorders
US9573948B2 (en) 2014-10-06 2017-02-21 Flatley Discovery Lab Triazolopyridine compounds and methods for the treatment of cystic fibrosis
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
GB201808575D0 (en) 2018-05-24 2018-07-11 Galapagos Nv Methods for the treatment of psoriatic arthrits
US20230056497A1 (en) * 2019-12-19 2023-02-23 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services CD206 Modulators Their Use and Methods for Preparation
CN119997982A (zh) 2022-09-09 2025-05-13 迈里克斯制药有限公司 包含nmt抑制剂的抗体药物偶联物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) * 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
EP1277754B8 (en) * 2000-04-27 2005-09-28 Astellas Pharma Inc. Imidazopyridine derivatives
OA12552A (en) * 2001-03-09 2006-06-06 Pfizer Prod Inc Triazolopyridines as anti-inflammatory agents.
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
AU2003249477A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Heterobicylcic metalloproteinase inhibitors
EP1601672B1 (en) * 2003-02-14 2006-07-26 Pfizer Products Inc. Triazolo-pyridines as anti-inflammatory compounds

Similar Documents

Publication Publication Date Title
JP2016164184A5 (cg-RX-API-DMAC10.html)
JP2021515036A5 (cg-RX-API-DMAC10.html)
JP2014516074A5 (cg-RX-API-DMAC10.html)
JP2015517566A5 (cg-RX-API-DMAC10.html)
RU2015139590A (ru) ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ
JP2008514643A5 (cg-RX-API-DMAC10.html)
JP2013521288A5 (cg-RX-API-DMAC10.html)
JP2013523710A5 (cg-RX-API-DMAC10.html)
JP2012502890A5 (cg-RX-API-DMAC10.html)
JP2021501220A5 (cg-RX-API-DMAC10.html)
ME02203B (me) Hinolin i hinoksalin derivati kao inhibitori kinaza
RU2017125025A (ru) Конденсированные кольцевые гетероарильные соединения и их применение в качестве ингибиторов trk
CA2596013A1 (en) Benzoimidazole derivatives and pharmaceutical composition comprising the same
JP2013521286A5 (cg-RX-API-DMAC10.html)
JP2011506480A5 (cg-RX-API-DMAC10.html)
HRP20192274T1 (hr) Novi derivati oktahidro-pirolo[3,4−c]-pirola i njihovi analozi kao inhibitori autotaksina
RU2019111882A (ru) Антагонисты trpv4
JP2014524461A5 (cg-RX-API-DMAC10.html)
RU2011147181A (ru) Азетидинилдиамиды в качестве ингибиторов моноациглицерин-липазы
JP2019532052A5 (cg-RX-API-DMAC10.html)
JP2013505969A5 (cg-RX-API-DMAC10.html)
JP2011528658A5 (cg-RX-API-DMAC10.html)
RU2003111754A (ru) Производные пиридина с активностью ингибирования /кв-киназы (/кк-бета)
JP2014509316A5 (cg-RX-API-DMAC10.html)
JP2013501720A5 (cg-RX-API-DMAC10.html)